Oncology Market Access 2011 is a conference that covers topics such as:
- Succeed in pricing negotiations and effective market access strategy
- The uncertainty in current pricing, increasing complexity and reimbursement environment in order to "Unlock" the Oncology Market Access 2011 across Europe
- Cost-effectiveness measures & the impact on the industry
- Early patient access to new cancer drugs and the need for benefit/risk data
- Market access as part of the entire drug’s life cycle
- Market access as an integral part of the pharma company
- The role of HTAs
- New market access model?
- Healthcare & hospital budgets challenges
- Funding of new cancer drugs
- The concept of risk-sharing
Oncology Market Access brings together executives and Managers from the pharmaceutical industry that are involved in Market Access, Oncology, Health Economics & Outcomes Research, Pricing & Reimbursement, Medical affairs, Oncology Marketing, Public Affairs, Governmental Affairs, Country Managers, Therapeutic Area Heads, Government bodies, HTA agencies and Regulatory Bodies.
